 |
|
Subretinal Surgery for Choroidal Neovascularization in Patients With High Myopia
Akinori Uemura, MD;
Matthew A. Thomas, MD
Arch Ophthalmol. 2000;118:344-350.
Objective To analyze the visual outcome in patients undergoing surgical removal of subfoveal choroidal neovascularization (CNV) in eyes with high myopia.
Methods We retrospectively reviewed the medical records of 48 consecutive patients with high myopia ( 6 diopters [D]) who underwent vitrectomy with surgical removal of subfoveal CNV. The patient population consisted of 2 groups. Group 1 included 23 patients with findings only of myopic degeneration, and group 2 included 25 patients with presumed ocular histoplasmosis syndrome and myopia of 6 D or more.
Results In group 1, the visual acuity improved by 2 or more Snellen lines in 9 eyes (39%), decreased in 8 eyes (35%), and remained unchanged in 6 (26%), with a mean follow-up of 24 months (range, 8-60 months). The preoperative visual acuity was 20/40 or better in only 1 eye (4%), but 8 (35%) achieved a final visual acuity of 20/40 or better. In group 2, the visual acuity improved in 16 eyes (64%), was stable in 4 (16%), and deteriorated in 5 (20%), with a mean follow-up of 18 months (range, 6-44 months). Only 3 eyes (12%) had a preoperative visual acuity of 20/40 or better, but 11 (44%) achieved a final visual acuity of 20/40 or better. Recurrence occurred in 13 (57%) of the 23 eyes in group 1 and in 9 (36%) of the 25 eyes in group 2. Univariate analysis demonstrated a significant relation between younger patient age (group 1) and absence of postoperative CNV recurrence (group 2) and an improvement of visual acuity (P<.01).
Conclusions Surgical removal of CNV may provide visual benefit in selected cases of subfoveal CNV associated with high myopia. The determination of whether surgical intervention is appropriate in these cases requires a prospective, randomized, clinical trial.
From the Barnes Retina Institute, St Louis, Mo. Dr Uemura is now with the Department of Ophthalmology, Kagoshima University Faculty of Medicine, Kagoshima, Japan. Neither of the authors has a proprietary interest in any of the material used in this study.
RELATED ARTICLE
Archives of Ophthalmology Reader's Choice: Continuing Medical Education
Arch Ophthalmol. 2000;118(3):456.
FULL TEXT
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
Intravitreal bevacizumab (Avastin) as treatment for subfoveal choroidal neovascularisation secondary to pathological myopia
Yamamoto et al.
Br. J. Ophthalmol. 2007;91:157-160.
ABSTRACT
| FULL TEXT
Choroidal neovascularisation in pathological myopia: an update in management
Chan et al.
Br. J. Ophthalmol. 2005;89:1522-1528.
ABSTRACT
| FULL TEXT
Change in Full-Field ERGs after Macular Translocation Surgery with 360{degrees} Retinotomy
Terasaki et al.
IOVS 2002;43:452-457.
ABSTRACT
| FULL TEXT
Surgical removal of subfoveal choroidal neovascularisation in highly myopic patients
Ruiz-Moreno and de la Vega
Br. J. Ophthalmol. 2001;85:1041-1043.
ABSTRACT
| FULL TEXT
|
